Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Published 30/03/2023, 17:43
© Reuters Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga - Gainers

  • SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront payment of $90 million.
  • Palisade Bio, Inc. (NASDAQ: PALI) rose 49% to $2.51 after Maxim Group upgraded the stock from Hold to Buy and announced a $50 price target.
  • National CineMedia, Inc. (NASDAQ: NCMI) jumped 32.1% to $0.1510. National CineMedia is preparing for Chapter 11 filing, the Wall Street Journal reported last week.
  • Boxed, Inc. (NYSE: BOXD) jumped 31.9% to $0.2120 after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives.
  • Accelerate Diagnostics, Inc. (NASDAQ: AXDX) surged 27.5% to $0.64 after the company reported better-than-expected Q4 sales results.
  • EVgo, Inc. (NASDAQ: EVGO) shares gained 24.4% to $7.17 after the company reported that fourth-quarter sales nearly quadrupled year-on-year to $27.30 million, beating the consensus of $21.82 million.
  • Toro Corp. (NASDAQ: TORO) climbed 21% to $2.36 after gaining around 20% on Wednesday.
  • Puma Biotechnology, Inc. (NASDAQ: PBYI) gained 20.6% to $3.0750.
  • Safe & Green Holdings Corp. (NASDAQ: SGBX) shares climbed 18.8% to $0.96 after the company reported Q4 results.
  • Conformis, Inc. (NASDAQ: CFMS) jumped 18.5% to $1.79. Conformis recently posted upbeat quarterly results.
  • Digital Media Solutions, Inc. (NYSE: DMS) rose 18.5% to $0.9507. The company recently signed an agreement to acquire the HomeQuote.io home services marketplace from Customer Direct Group, along with their brand direct international ad network.
  • YS Biopharma Co., Ltd. (NASDAQ: YS) gained 17.2% to $2.3797.
  • Eos Energy Enterprises, Inc. (NASDAQ: EOSE) rose 17.1% to $2.46. Eos Energy Enterprises recently reported worse-than-expected Q4 sales results.
  • Adamas One Corp. (NASDAQ: JEWL) gained 15.2% to $0.91.
  • F45 Training Holdings Inc. (NYSE: FXLV) jumped 15% to $1.42.
  • Sprinklr, Inc. (NYSE: CXM) gained 15% to $12.52 after the company reported better-than-expected Q4 EPS and sales results.
  • LightInTheBox Holding Co., Ltd. (NYSE: LITB) climbed 14.5% to $1.66. LightInTheBox named CEO Jian He as Chairman effective March 29 after Zhi Yan resigned due to personal reasons.
  • Fluence Energy, Inc. (NASDAQ: FLNC) gained 13.9% to $18.49. Goldman Sachs upgraded Fluence Energy from Neutral to Buy and raised the price target from $25 to $29.
  • Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) climbed 13.6% to $22.93. Arcturus Therapeutics recently reported better-than-expected Q4 EPS and sales results.
  • NaaS Technology Inc. (NASDAQ: NAAS) gained 13.1% to $8.79.
  • Mullen Automotive, Inc. (NASDAQ: MULN) rose 13.1% to $0.1176 after jumping 11% on Wednesday.
  • Emergent BioSolutions Inc. (NYSE: EBS) gained 11.5% to $10.43 after the FDA approved over-the-counter designation to the company's NARCAN nasal spray.
  • Alpine Acquisition Corporation (NASDAQ: REVE) shares rose 11.2% to $10.56.
  • RenovoRx, Inc. (NASDAQ: RNXT) shares gained 10.7% to $4.3189 after the company announced new data from Phase III clinical trial interim analysis.
  • Better Therapeutics, Inc. (NASDAQ: BTTX) surged 10.6% to $0.7034 after the company reported better-than-expected Q4 EPS results.
  • Cazoo Group Ltd (NYSE: CZOO) shares rose 9.4% to $2.6156 after jumping 15% on Wednesday.
  • Kohl's Corporation (NYSE: KSS) gained 7.2% to $23.65.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • mCloud Technologies Corp. (NASDAQ: MCLD) shares dipped 43% to $0.4101. mCloud announced receipt of Nasdaq notification letter regarding minimum bid price deficiency.
  • Sonida Senior Living, Inc. (NASDAQ: SNDA) fell 33.3% to $7.16 after reporting downbeat Q4 results.
  • AngioDynamics, Inc. (NASDAQ: ANGO) fell 24.3% to $9.38 after the company posted downbeat Q3 results and lowered FY23 outlook.
  • Semtech Corporation (NASDAQ: SMTC) fell 23.1% to $24.71 after posting downbeat Q4 earnings.
  • Dragonfly Energy Holdings Corp. (NASDAQ: DFLI) shares dipped 22.8% to $3.4299 after the company reported worse-than-expected Q4 sales.
  • Blue Star Foods Corp. (NASDAQ: BSFC) fell 22.2% to $0.1220.
  • Cyxtera Technologies, Inc. (NASDAQ: CYXT) dropped 22% to $0.5061. Starboard Value said on March 27, Jeff Smith resigned from board of Cyxtera and representatives of Starboard Value ceased serving as observers on board.
  • Bit Brother Limited (NASDAQ: BTB) fell 20.7% to $1.07.
  • China Automotive Systems, Inc. (NASDAQ: CAAS) dropped 19.9% to $4.8350. China Automotive Systems reported a fourth-quarter FY22 sales decline of 7.2% year-on-year to $128.80 million, missing the consensus of $138.46 million.
  • Laser Photonics Corporation (NASDAQ: LASE) fell 19% to $4.9699 after the company said it will postpone reporting its Q4 ended December 31, 2022.
  • Metropolitan Bank Holding Corp. (NYSE: MCB) fell 18.9% to $28.39.
  • LogicMark, Inc. (NASDAQ: LGMK) shares dropped 17.3% to $0.1610. LogicMark shares jumped over 39% on Wednesday after the company announced financial results for the year ended 2022.
  • G Medical Innovations Holdings Ltd (NASDAQ: GMVD) dipped 16.7% to $2.24.
  • Avidity Biosciences, Inc. (NASDAQ: RNA) dropped 16% to $16.96 as the company issued an update on Phase 1/2 MARINA trial of AOC 1001 in adults with myotonic dystrophy Type 1.
  • Franklin Covey Co. (NYSE: FC) fell 15.7% to $37.28 after the company reported worse-than-expected Q2 results.
  • Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 15% to $0.68 after the company entered a $300 million at the market offering program and issued weak Q4 guidance.
  • Codiak BioSciences, Inc. (NASDAQ: CDAK) fell 13.2% to $0.1823 after jumping over 10% on Wednesday. Codiak BioSciences voluntarily filed for protection under Chapter 11 bankruptcy.
  • TORM plc (NASDAQ: TRMD) fell 12.8% to $28.54 after the company reported commencement of a secondary public offering of 5 million of its Class A common shares by a selling shareholder.
  • Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) dropped 9.4% to $6.62.
  • ProQR Therapeutics N.V. (NASDAQ: PRQR) shares fell 7.5% to $2.33. ProQR Therapeutics filed prospectus relates to resale of up to 13.4 million shares by selling shareholders.
  • IHS Holding Limited (NYSE: IHS) fell 6.8% to $8.25. IHS Holding recently reported better-than-expected Q4 sales results.
  • Verint Systems Inc. (NASDAQ: VRNT) dropped 6.6% to $34.99 following Q4 resulst.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.